Track Zhengye Biotechnology Holding Limited — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Zhengye Biotechnology Holding Limited ZYBT · Stock Open Zhengye Biotechnology Holding Limited in new tab

1.52 USD
EPS
-0.21
P/B
1.97
ROE
-25.17
Loading chart...
Key Metrics
EPS-0.21
Book Value0.78
Price to Book1.97
Debt/Equity24.48
% Insiders16.164%
Growth
Revenue Growth-0.41%

DCF Valuation

Tweak assumptions to recompute fair value for Zhengye Biotechnology Holding Limited (ZYBT)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Zhengye Biotechnology Holding Limited Logo Zhengye Biotechnology Holding Limited Analysis (ZYBT)

China Healthcare Official Website Stock

Is Zhengye Biotechnology Holding Limited a good investment? Zhengye Biotechnology Holding Limited (ZYBT) is currently trading at 1.52 USD.

Investor FAQ

Does Zhengye Biotechnology Holding Limited pay a dividend?

No, it does not currently pay a dividend.

What asset class is Zhengye Biotechnology Holding Limited?

Zhengye Biotechnology Holding Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People's Republic of China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs, as well as monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. It also develops vaccines for household animals, including rabies vaccine and Strain Flury LEP for dogs. In addition, the company exports its products to Vietnam, Pakistan, and Egypt. It serves direct-end customers, including livestock farmers and local governments; and domestic distributors and exporting distributors. The company was incorporated in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.

Exchange Ticker
NASDAQ ZYBT
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion